Search results for "concomitant"

showing 10 items of 248 documents

Indications and contraindications of dental implants in medically compromised patients: update.

2013

The aim of this study was to review the current scientific literature in order to analyse the indications and contraindications of dental implants in medically compromised patients. A reference research was carried out on PubMed using the key words “implant” AND (oral OR dental) AND (systemic disease OR medically compromised), in articles published between 1993 and 2013. The inclusion criteria were the following: clinical studies in which, at least, 10 patients were treated, consensus articles, reviewed articles and meta-analysis performed in humans treated with dental implants, and which included the disease diagnosis. A total of 64 articles were found, from which 16 met the inclusion crit…

medicine.medical_specialtySystemic diseaseOsteoporosisMEDLINEOdontologíaDiseaseReviewRisk FactorsmedicineEndocrine systemHumansDiseaseGeneral DentistryContraindicationDental Implantsbusiness.industryContraindications:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryCiencias de la saludSurgerystomatognathic diseasesOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASSurgeryImplantbusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Interferon decreases serum lipid peroxidation products of hepatitis C patients

1994

Abstract Thiobarbituric acid reactive substances (TBARS) concentration in serum has been determined in healthy subjects and in patients suffering acute hepatitis and chronic cases of hepatitis C. Treatment with interferon of the chronic active hepatitis C patients, 5 × 10 6 U three times a week during 2 months, led in those patients whose SGPT activity normalized in serum, to a concomitant decrease in serum TBARS content. The possible theoretical involvement of peroxidation and antioxidants in this beneficial effect of interferon in hepatitis C patients is discussed. The results presented confirm the value of TBARS as laboratory test in the management of liver diseases and as a useful tool …

medicine.medical_specialtyThiobarbituric acidHIV InfectionsThiobarbituric Acid Reactive SubstancesBiochemistryGastroenterologyHepatitisLipid peroxidationchemistry.chemical_compoundInterferonPhysiology (medical)Internal medicineTBARSHumansMedicineIn patientHepatitis ChronicHepatitisSuperoxide Dismutasebusiness.industryHepatitis Cmedicine.diseaseHepatitis CLipidschemistryConcomitantAcute DiseaseImmunologyInterferonsLipid Peroxidationbusinessmedicine.drugFree Radical Biology and Medicine
researchProduct

Simultaneous cardiocerebral embolization in patients with atrial fibrillation

2020

medicine.medical_specialtyTime Factorsmedicine.medical_treatment[SDV]Life Sciences [q-bio]Myocardial Infarction030204 cardiovascular system & hematologyRisk AssessmentDecision Support Techniques03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineAtrial FibrillationIschaemic strokemedicineHumansThrombolytic TherapyIn patientMyocardial infarctionEmbolizationAngioplasty Balloon CoronaryIschemic StrokeThrombectomybusiness.industryAtrial fibrillationGeneral Medicinemedicine.diseaseCoronary embolismTreatment OutcomeIntracranial EmbolismConcomitantCardiologyStentsCardiology and Cardiovascular MedicinebusinessAlgorithms030217 neurology & neurosurgery
researchProduct

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary …

2001

Abstract OBJECTIVES We sought to determine the effectiveness of primary angioplasty compared with thrombolysis in clinical practice. BACKGROUND In clinical practice, primary angioplasty for the treatment of acute myocardial infarction (AMI) has not yet been proven more effective than intravenous thrombolysis, nor have subgroups of patients been identified who would perhaps benefit from primary angioplasty. METHODS The pooled data of two AMI registries—the Maximal Individual TheRapy in Acute myocardial infarction (MITRA) study and the Myocardial Infarction Registry (MIR)—were analyzed. A total of 9,906 lytic-eligible patients with AMI, with a pre-hospital delay of ≤12 h, were treated with ei…

medicine.medical_specialtyUnivariate analysisbusiness.industrymedicine.medical_treatmentAbsolute risk reductionThrombolysisOdds ratiomedicine.diseaseConfidence intervalInternal medicineConcomitantAngioplastyCardiologyMedicineMyocardial infarctionbusinessCardiology and Cardiovascular MedicineJournal of the American College of Cardiology
researchProduct

Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis

2018

Fulvio Braido,1 Pierachille Santus,2 Angelo Guido Corsico,3 Fabiano Di Marco,4 Giovanni Melioli,5 Nicola Scichilone,6 Paolo Solidoro7 1Department of Internal Medicine, IRCCS San Martino di Genova University Hospital, Genoa, Italy; 2Department of Biomedical and Clinical Sciences, University of Milan, Division of Respiratory Diseases, “L. Sacco” University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy; 3Department of Internal Medicine and Therapeutics, Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, University of Pavia, Italy; 4Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy; 5Center for Precision Medici…

medicine.medical_specialtyValidation studyConcordance analysisbusiness.industryGeneral MedicinePrimary careInternational Journal of Chronic Obstructive Pulmonary Diseasemedicine.diseasecomputer.software_genreObstructive lung diseaseExpert system03 medical and health sciences0302 clinical medicine030228 respiratory systemSample size determinationConcomitantEmergency medicinemedicine030212 general & internal medicineMedical diagnosisbusinesscomputerInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study

2019

Background: Transverse sinus stenosis is a common brain MRI finding in chronic migraine (CM) and chronic tension-type headache (CTTH) patients in clinical practice; however, its clinical and diagnostic role is unclear. The aim of the study is to determine the frequency of transverse sinus stenosis in these headache patients resistant to preventive treatments and to verify whether this is a useful finding for identifying patients with intracranial hypertension. Methods: This is an observational study. Patients with refractory CM and CTTH underwent a 3T-magnetic resonance venography (MRV) before cerebrospinal fluid (CSF) opening pressure measurement. Transverse sinus stenosis was determined u…

medicine.medical_specialtyVenographylcsh:RC346-429030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineCerebrospinal fluidChronic Migrainechronic headacheInternal medicinemedicineRisk factorlcsh:Neurology. Diseases of the nervous systemSinus (anatomy)Original Researchmedicine.diagnostic_testbusiness.industrysinus stenosisrefractory headachemedicine.diseaseComorbidityStenosismedicine.anatomical_structureNeurologyConcomitantCardiologyNeurology (clinical)businessidiopathic intracranial hypertension030217 neurology & neurosurgeryMRIFrontiers in Neurology
researchProduct

Is GH dosing optimal in female patients with adult-onset GH deficiency? An analysis from the NordiNet® International Outcome Study

2017

SummaryObjective To evaluate gender differences in GH dosing, IGF-I and cardiovascular risk markers in adults with GH deficiency (GHD). Design NordiNet® International Outcome Study (NCT00960128), a noninterventional, multicentre study, evaluates the long-term effectiveness and safety of Norditropin® (Novo Nordisk A/S) in the real-life clinical setting. Patients Nondiabetic patients (n = 252; 41·7% female) with adult-onset GHD (age ≥20 years at GH start), ≥4 years’ GH therapy and glycosylated haemoglobin (HbA1c) data at baseline and 4 years. Measurements Effects of gender (adjusted for baseline age and body mass index [BMI], average GH dose, treatment duration and concomitant medication) on …

medicine.medical_specialtyWaistmedicine.diagnostic_testbusiness.industryEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematology03 medical and health sciencesDose–response relationship0302 clinical medicineEndocrinologyEndocrinologyInternal medicineConcomitantmedicineDosingYoung adultbusinessLipid profileBody mass indexGH DeficiencyClinical Endocrinology
researchProduct

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentratio…

2015

Background: OMA is an effective treatment option in SAA. However, little data are available on the long-term-efficacy oft the drug. Objective: To determine the long-term efficacy of OMA in respect to clinical parameters and IgE serum levels. Methods: This was a retrospective, open-label, uncontrolled, multi-center observational study according to the definition of non-interventional studies. 22 non-smoking patients (10 m, 12 f; mean age 47,9 yrs) with SAA were enrolled. Pat were treated with OMA up to for 4 years and total serum IgE levels were assessed at initiation of therapy, after 2-6 ms and 3-5 yrs. Data were recorded on standardized CRFs by the treating physician. Results: The average…

medicine.medical_specialtybiologybusiness.industryAllergic asthmaAtopic dermatitisOmalizumabImmunoglobulin Emedicine.diseaseGastroenterologyTreatment periodSerum igeFood allergyInternal medicineConcomitantImmunologybiology.proteinmedicinebusinessmedicine.drug5.3 Allergy and Immunology
researchProduct

Bone marrow punctures and pain

2004

Abstract We prospectively analysed pain in 263 patients induced by a frequent diagnostic procedure for oncologists, specifically the bone marrow puncture. Substantial pain (5 and more out of 10 on a numerical rating scale) was reported by 30.4% of patients, but physicians did not realize this procedure-related pain of patients in more than 50% of such punctures. The necessity for improved analgesia is emphasized by the fact, that at least 50% of patients experiencing substantial pain wished to receive concomitant medication in future punctures. Duration of the procedure was identified as sole independent predictive factor for patients’ pain intensity, while patients’ characteristics like ge…

medicine.medical_specialtybusiness.industryAnesthesiology and Pain Medicinemedicine.anatomical_structurePain controlRating scaleConcomitantAmbulatoryEmergency MedicinePhysical therapyMedicineSevere painPremedicationBone marrowAugmentbusinessAcute Pain
researchProduct

Concomitant history of cancer in acute pulmonary embolism is connected with poorer outcome

2015

Abstract Purpose: Cancer increases the risk of venous thromboembolism (VTE) substantially. VTE is connected with poorer outcome in cancer patients. The aim of our study was to investigate the impact of cancer on the severity and short-term outcome of pulmonary embolism (PE). Methods: We retrospectively analyzed the data of 182 patients with confirmed PE. PE patients were subdivided in the group with concomitant active cancer disease or history of cancer or in the group without cancer. Groups were compared with Wilcoxon–Mann–Whitney Test. Logistic regression models were calculated to investigate the association between cancer and several parameters such as age and PE severity status as well …

medicine.medical_specialtybusiness.industryCancerHematologyV q scanDiseasemedicine.diseaseLogistic regressionPulmonary embolismSurgeryOncologyInternal medicineConcomitantTroponin ImedicinebusinessVenous thromboembolismActa Haematologica Polonica
researchProduct